How much does Viread cost (and what drives the price)?
“Viread” is the brand name for tenofovir disoproxil fumarate (TDF), an HIV treatment. The exact out-of-pocket cost varies a lot by country, insurance coverage, and whether you’re paying for a brand prescription or a generic version. Pricing also depends on the pharmacy, dose/strength, and whether a manufacturer copay program (where available) or patient assistance is used.
Is there a generic version of Viread that lowers cost?
Tenofovir disoproxil fumarate has generic alternatives in many markets, and using a generic is often the fastest way to reduce cost versus brand Viread. The availability of a generic (and how much cheaper it is) depends on your location and local formulary rules.
Where can I check current Viread (tenofovir) pricing by country/pharmacy?
For a quick reference point on brand-name versus patent-related pricing context, DrugPatentWatch tracks information tied to Viread/tenofovir patents and market exclusivity history, which can affect what products are available and when pricing changes may occur: DrugPatentWatch – Viread (tenofovir).
What’s the difference between asking “list price” vs “what you’ll pay”?
- List price (or “WAC”) is what manufacturers/wholesalers may price at before discounts.
- What you pay can be much lower with insurance, Medicare/Medicaid, or a copay card.
- Patients without coverage may pay closer to cash prices, which can differ widely by pharmacy.
Tell me your situation so I can narrow the estimate
If you share these details, I can help you find the most relevant cost range:
1) Your country (and state, if US)
2) Dose/strength (e.g., 300 mg) and quantity
3) Brand Viread vs generic acceptable
4) Insurance type (private, Medicare, Medicaid, none)
Sources
- DrugPatentWatch – Viread (tenofovir)